Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102381918A details a safe copper-catalyzed route to benzyl cyanides using potassium ferrocyanide, offering significant cost and safety advantages for supply chains.
Patent CN103787942B reveals a scalable HWE reaction route for lubiprostone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102675135A details a mild, high-yield method for synthesizing alpha-amino acid esters using triethylamine catalysis, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN105949079A enables green synthesis of pharmaceutical intermediates. Visible light catalysis ensures high purity and supply chain reliability for global buyers.
Novel Rh-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates with AURKA inhibitory activity and scalable production capabilities.
Patent CN107629020B reveals a metal-free synthesis route for 4H-1,2,4-oxadiazine-5(6H)-one derivatives, offering cost-effective manufacturing for agrochemical and pharmaceutical intermediates.
Novel patent CN117342999A enables green synthesis of H3R modulators. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110156809A ionic liquid method offers high purity and cost reduction in fine chemical manufacturing for global supply chains ensuring reliable delivery.
Patent CN110963900A details a metal-free oxidative decarboxylation method using 4CzIPN and air, offering a green route for high-purity pharmaceutical intermediates manufacturing.
Novel sulfuric acid salification method ensures high purity 2-bromo-4-chloropyridine. Eliminates column chromatography for cost reduction in pharma manufacturing.
Patent CN103483306B reveals water-based polyamino ionic liquid catalysis for high-purity chromene derivatives, offering scalable cost reduction and supply reliability.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.
Patent CN102311440B details a novel 5-step synthesis for high-purity diazabicyclo octane intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105669517A reveals metal-free indole synthesis offering cost reduction in pharmaceutical intermediates manufacturing and high-purity indole compounds for global supply chains.
Patent CN102351907A reveals a nickel-mediated transmetallation route for diverse metal-NHC catalysts, offering cost-effective manufacturing for pharmaceutical and fine chemical applications.
Patent CN101910148B reveals a novel crystallization process for dodecahydro-naphtho-furanyl-carbamate intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel patent CN104311536A details high-yield lenalidomide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113563305B reveals a cost-effective, high-yield route for 2-(4-phenoxyphenyl)-6-(N-substituted oxycarbonyl piperidine-4-) nicotinamide, ensuring reliable supply chain stability.
Patent CN105693621A details a novel oxidative sulfonylation method using stable sulfinate salts, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN110698369B reveals a mild visible-light method for synthesizing arylacetylene alkyl sulfones using alkyl fluoroborates, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.